Hong-Hu Zhu

Zhejiang University - Department of Hematology

China

SCHOLARLY PAPERS

2

DOWNLOADS

272

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Venetoclax Plus “3+7” Chemotherapy As the First-Line Therapy for Adult Patients With Acute Myeloid Leukemia

Number of pages: 47 Posted: 31 Jan 2022
Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, affiliation not provided to SSRN, Zhejiang University - Bone Marrow Transplantation Center, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Ningbo University, Zhejiang University - Department of Hematology, affiliation not provided to SSRN, Zhejiang University - Department of Hematology, affiliation not provided to SSRN, affiliation not provided to SSRN, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, affiliation not provided to SSRN, Zhejiang University - Zhejiang Provincial Key Laboratory of Pancreatic Disease, Peking University - Clinical Research Institute, Zhejiang University - Department of Hematology and Zhejiang University - Department of Hematology
Downloads 213 (309,755)

Abstract:

Loading...

Acute myeloid leukemia, Venetoclax, Response, Safety.

2.

CAG Regimen for Refractory or Relapsed Adult T-Cell Acute Lymphoblastic Leukemia: A Retrospective, Multicenter, Cohort Study

Number of pages: 28 Posted: 21 Sep 2019
Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Government of the People's Republic of China - Department of Hematology, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Government of the People's Republic of China - Changzheng Hospital, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Shulan (Hangzhou) Hospital, Government of the People's Republic of China - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Shaoxing Central Hospital, Peking University, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology and Zhejiang University - Department of Hematology
Downloads 59 (785,192)
Citation 1

Abstract:

Loading...

T-cell acute lymphoblastic leukemia; refractory or relapse; stem cell transplantation